跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
recombinant VEGF-165
首页
药物
recombinant VEGF-165
recombinant VEGF-165
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Fibrin/fibrinogen-binding conjugate
US 7091325 B2
申请人: BAXTER INT
优先权: 2003
US
Ischemic-myocardium-targeted VEGF (vascular endothelial growth factor) recombinant protein
CN 106279425 A
申请人: INST GENETICS & DEV BIOLOG CAS
优先权: 2015
CN
Recombinant human VEGF tumor polypeptide vaccine
CN 106806890 A
申请人: INST OF MEDICAL BIOLOGY CHINESE ACAD OF MEDICAL SCIENCES
优先权: 2016
CN
Construction of double-gene adenovirus vector carrying vascular endothelial growth factor and hepatocyte growth factor
CN 112080523 A
申请人: SHIYAN RENMIN HOSPITAL HUBEI MEDICAL COLLEGE AFFILIATED PEOPLES HOSPITAL
优先权: 2020
CN
Anti-human VEGF-165 antibody as well as preparation method and application thereof
CN 120775044 A
申请人: SHANGHAI INST OF PHARMACEUTICAL INDUSTRY CO LTD
优先权: 2024
CN
药物
反馈